In vitro β-catenin attenuation by a mefloquine-loaded core–shell nano emulsion strategy to suppress liver cancer cells
2025

New Nano Emulsion Strategy to Fight Liver Cancer

Sample size: 27 publication 10 minutes Evidence: high

Author Information

Author(s): Priyadarshini Mohapatra, N. Chandrasekaran

Primary Institution: Vellore Institute of Technology

Hypothesis

Can a mefloquine-loaded nano emulsion effectively target the Wnt/β-catenin pathway to suppress liver cancer cell growth?

Conclusion

The study found that the mefloquine-loaded core-shell nano emulsion significantly induced apoptosis in liver cancer cells and downregulated the Wnt/β-catenin pathway.

Supporting Evidence

  • The core-shell nano-emulsion showed high stability and excellent biosafety.
  • MQ/GNE-GNP induced significant apoptosis in HepG2 cells.
  • The formulation downregulated nuclear β-catenin expression.
  • Cell cycle analysis indicated increased sub G0/G1 phase population in treated cells.
  • Reactive oxygen species levels increased in cancer cells treated with MQ/GNE-GNP.

Takeaway

Scientists created a special tiny bubble that carries a medicine to help fight liver cancer by stopping cancer cells from growing.

Methodology

The study involved formulating a mefloquine-loaded garlic nano-emulsion and testing its effects on human liver cancer cells through various assays.

Potential Biases

Potential bias in the selection of cell lines and experimental conditions.

Limitations

The study primarily focused on in vitro results, which may not fully translate to in vivo effectiveness.

Participant Demographics

Human liver cancer cell line (HepG2) derived from a 15-year-old male.

Statistical Information

P-Value

0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1039/d4na00547c

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication